Korro Bio price target raised to $10 from $7 at Clear Street

Clear Street raised the firm’s price target on Korro Bio (KRRO) to $10 from $7 and keeps a Hold rating on the shares following the analyst day. The company’s lead program KRRO-121 is advancing into the clinic this year for hyperammonemia, the analyst tells investors in a research note. Clear increased its likelihood of success on the program as it now sees a “clear rationale.”